Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancers receiving moderately emetogenic chemotherapy regimens

2018 ◽  
Vol 149 ◽  
pp. 161-162
Author(s):  
C. Weinstein ◽  
K. Jordan ◽  
S. Green ◽  
S. Khanani ◽  
E. Beckford-Brathwaite ◽  
...  
Keyword(s):  
Single Dose ◽  
Emetogenic Chemotherapy ◽  
Nausea And Vomiting ◽  
Moderately Emetogenic Chemotherapy ◽  
Gynecologic Cancers

Phase III design for a trial of single-dose fosaprepitant (FA) in preventing chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. TPS9664-TPS9664
Author(s):  
Stephen Joseph Noga ◽  
Cindy Weinstein ◽  
Elber S Camacho ◽  
Saleem A Khanani ◽  
Elizabeth Beckford-Brathwaite ◽  
...  
Keyword(s):  
Single Dose ◽  
Emetogenic Chemotherapy ◽  
Nausea And Vomiting ◽  
Phase Iii ◽  
Moderately Emetogenic Chemotherapy

The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy

1998 ◽  
Vol 6 (4) ◽  
pp. 389-395 ◽  
Author(s):  
J. J. Rusthoven ◽  
David Osoba ◽  
Charles A. Butts ◽  
Louise Yelle ◽  
Helen Findlay ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Emetogenic Chemotherapy ◽  
Nausea And Vomiting ◽  
Moderately Emetogenic Chemotherapy ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document